Product Categories
Country: | China |
---|---|
Tel: | 020-81960175 |
Mobile: | 18933936954 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
DL-2-Aminoheptanedioic acid | C7H13NO4 | 627-76-9 | Details |
N-Cbz-L-isoleucine | C14H19NO4 | 3160-59-6 | Details |
Bumetanide Impurity 80 | Details |
Halometasone Impurity N1 | C20H23ClF2O3 | 136132-00-8 | Details |
Cannabichromene | C21H30O2 | 20675-51-8 | Details |
Norepinephrine Impurity 85 HCl | Details |
Alendronic Acid Impurity 7 | Details |
2-Amino-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide (Clonazepam Impurity) | C15H12ClN3O4 | 17714-02-2 | Details |
Cefaclor Impurity 23 | C13H13N3O6S | 1426173-90-1 | Details |
Cabe Palace Suya Inkstone II TFA | Details |
1,2-Dioctanoylglycerol | C19H36O5 | 1069-87-0 | Details |
Cabe Palace Suya Inkstone I TFA | Details |
Perindoprilat-d4 | C17H28N2O5 | 1356841-18-3 | Details |
Halometasone Impurity N2 | C21H25ClF2O5 | 80157-55-7 | Details |
Isopropyl 2-(4-Isobutylphenyl)Propanoate | C16H24O2 | 64622-17-9 | Details |
Trimebutine EP Impurity D | C22H29NO5 | 92414-09-0 | Details |
Mianserin impurity 42 | Details |
H-4-Chloro-Phe-OH | C9H10ClNO2 | 14173-39-8 | Details |
Methotrexate Impurity 17 HBr | C7H8Br2N6 | 52853-40-4 | Details |
Empagliflozin Impurity 97 | C13H10ClIO | 1459754-32-5 | Details |
Ivabradine Impurity 7 | C16H24N2O3 | 85175-77-5 | Details |
Benzyl-d7 Alcohol | C7HD7O | 71258-23-6 | Details |
Cefaclor Oxide Impurity | Details |
Epinastine Impurity 28 | C8H5NOS | 532-55-8 | Details |
Prilocaine Impurity 8 DiHCl | C8H12N2 | 13438-26-1 | Details |
Ciclesonide 22S-Epimer | C32H44O7 | 141845-81-0 | Details |
Epinastine Impurity 30 | C23H21N3OS | Details |
Labetalol Impurity 31 | Details |
Dinoprost trometamol | C24H45NO8 | 38562-01-5 | Details |
Sodium glycollate | C2H3NaO3 | 2836-32-0 | Details |
24703-35-3 Bicyclo(8.1.0)undeca-2,6-diene, 3,7,11,11-tetramethyl-, (1S-(1R*,2E,6E,10S*))- Bicyclogermacrene (+)-Bicyclogermacrene Bicyclogermacren | C15H24 | 24703-35-3 | Details |
Tiopronin Impurity 4 | C3H6O2S | 79-42-5 | Details |
Propionyl Bromide | C3H5BrO | 598-22-1 | Details |
Avanafil Impurity 101 | C5H11NO | 770697-08-0 | Details |
Phosphoric acid methyl ester | CH4O.xH3O4P | 12789-45-6 | Details |
Bicalutamide Impurity 13 | C12H9F3N2O | 90357-53-2 | Details |
Methotrexate impurity N3 | C22H26N8O5 | 65148-64-3 | Details |
Withanoside IV | C40H62O15 | 362472-81-9 | Details |
Argatroban Impurity 33 | C15H29ClN6O5 | 74874-08-1 | Details |
Lumateperone Impurity 17 HCl | Details |
(-)-Globulol(sum of enantiomers) | C15H26O | 489-41-8 | Details |
Rocuronium Impurity 17 | C19H28O | 963-75-7 | Details |
Axitinib Impurity N1 | C22H21N7O | 1420478-90-5 | Details |
α-Gurjunene | C15H24 | 489-40-7 | Details |
Linezolid Impurity86 HCl | C15H22FN3O3 | 333753-69-8 | Details |
Fulvic acid | C14H12O8 | 479-66-3 | Details |
Upadacitinib-15N-d2 | Details |
Oxoadipicacid | C6H8O5 | 3184-35-8 | Details |
D-Methionine | C5H11NO2S | 348-67-4 | Details |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine | C6H7F3N4 | 486460-21-3 | Details |
Epinastine Impurity 44 Fumarate | C19H20N2O4 | 127785-96-0 | Details |
Mepivacaine EP Impurity D HCl | Details |
Lurasidone Impurity 19 | C8H14Cl2 | 61169-66-2 | Details |
Lurasidone Impurity 20 | C31H38N6O2S2 | Details |
Empagliflozin impurity 02 | Details |
Etomidate Impurity 8 | C12H17NO2 | 66512-37-6 | Details |
2-Sulfamoylbenzoic acid | C7H7NO4S | 632-24-6 | Details |
Bisoprolol | C18H31NO4 | 66722-44-9 | Details |
Arachidic Acid | C20H40O2 | 506-30-9 | Details |
Linezolid Impurity 94 | Details |
Cisatracurium Besilate EP Impurity O | C6H5O3S- | Details |
N-(1-(5,6-Dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride | C22H25ClF3N | 2514708-62-2 | Details |
2,3,5-Trichloro-1,4-benzoquinone | C6HCl3O2 | 634-85-5 | Details |
Lipase AY 30 | C11H9N3NaO2+ | 9001-62-1 | Details |
2,6-Di-sec-butylphenol | C14H22O | 5510-99-6 | Details |
Nafamostat | C19H17N5O2 | 81525-10-2 | Details |
N-Phenyl-N'-(2-methylphenyl)-p-phenylenediamine | C19H18N2 | 27173-16-6 | Details |
Crizotinib Impurity 01 | C26H30Cl2FN5O3 | 877399-51-4 | Details |
4-O-Feruloylquinic acid | C17H20O9 | 2613-86-7 | Details |
2-(3-((4-Amino-2-methylpyrimidin-5-yl)methyl)-4-methylthiazol-3-ium-5-yl)ethyl hydrogen phosphate | C12H17N4O4PS | 495-23-8 | Details |
Dihydro Vitamin K1 | C31H48O2 | 572-96-3 | Details |
Butyl 2-bromoacetate | C6H11BrO2 | 18991-98-5 | Details |
2,4-Dihydroxybenzaldehyde | C7H6O3 | 95-01-2 | Details |
Betamethasone benzoate | C35H41FO8 | 22298-29-9 | Details |
Galegine | C6H13N3 | 543-83-9 | Details |
2-Hydroxy-4-n-hexyloxybenzophenone | C19H22O3 | 3293-97-8 | Details |
(6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoic Acid | C24H36O2 | 68378-49-4 | Details |
Methyl 3-((2-methoxy-2-oxoethyl)thio)-2-methylpropanoate | C8H14O4S | 38293-65-1 | Details |
Baloxavir impurity C94 | C27H24FN3O7S | 1985606-40-3 | Details |
Difenzoquat | C17H17N2+ | 49866-87-7 | Details |
2-((1R,3S,4S)-4-Methyl-3-(prop-1-en-2-yl)-4-vinylcyclohexyl)propan-2-ol | C15H26O | 639-99-6 | Details |
Acalabrutinib Impurity N1 | C26H23N7O2 | 1952316-43-6 | Details |
Potassium 2-mercaptoacetate | C2H3KO2S | 34452-51-2 | Details |
Diethyl 2-(6-bromohexyl)malonate | C13H23BrO4 | 6557-85-3 | Details |
Adapalene Impurity 3 | C17H22O | 726-94-3 | Details |
Clenbuterol EP Impurity B | C12H16Cl2N2O | 69708-36-7 | Details |
Nafamostat Impurity 15 | C7H5NO3 | 619-68-1 | Details |
Progesterone Impurity N2 | C22H34O2 | 40736-33-2 | Details |
Trimethylhexamethylene Diisocyanate (2,2,4- and 2,4,4- mixture) | C11H18N2O2 | 28679-16-5 | Details |
Propan-2-ylidenehydrazine | C3H8N2 | 5281-20-9 | Details |
Fospropofol Disodium Salt | C13H19O5P.2Na | 258516-87-9 | Details |
Bis(2-chloroethyl)amine | C4H9Cl2N | 334-22-5 | Details |
2-Oxo-2-(piperidin-1-yl)acetic acid | C7H11NO3 | 4706-33-6 | Details |
Methyl 4-methyl-3-oxotetrahydrothiophene-2-carboxylate | C7H10O3S | 2689-70-5 | Details |
Lauroscholtzine | C20H23NO4 | 2169-44-0 | Details |
Propyl Bromoacetate | C5H9BrO2 | 35223-80-4 | Details |
5-Nitro-2-Benzimidazolinone | C7H5N3O3 | 93-84-5 | Details |
n-Hentetracontane | C41H84 | 7194-87-8 | Details |
2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(n-octyloxy)phenol | C33H39N3O2 | 2725-22-6 | Details |
Product Total: Product Page: | ||||
57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 |